U.S. firm Storable to ramp up hiring for Hyderabad facility
March 27, 2024
Dive into China’s growing streaming industry
March 18, 2024
Writer-turned-lawmaker’s pursuit for better rural China
March 26, 2024
London: BridgeBio Pharma has granted German drugmaker Bayer an exclusive license to commercialise its heart disease drug in Europe, the ...
New Delhi, Sun Pharma on Wednesday said it has inked a pact with Bayer to market a drug for the ...
Bayer Pharma is not only seeing India as potential high growth market but also as a hub for innovation, R&D ...
New York: Bayer AG plans to spend $1 billion on drug research and development in the U.S. this year as ...
Bayer launched its drug finerenone to treat chronic kidney disease (CKD) associated with type-2 diabetes in India on Thursday. The ...
Mumbai: Bayer Pharma announced the launch of Finerenone under the brand name Kerendia, first-in-class non-steroidal, selective mineralocorticoid receptor antagonist indicated ...
Drugmaker Bayer on Thursday said it has introduced a medication for the treatment of chronic kidney disease associated with diabetes ...
The consumer health division of Bayer is betting big on India. The Basel-headquartered drug maker plans to bring more over-the-counter ...
Ranchi, March 31, 2022: Bayer, a global enterprise with core competencies in the life science fields of health care and ...
Bayer, a global enterprise with core competencies in the life sciences field of healthcare and nutrition, on Thursday said it ...
Copyright © 2021 Asia Post.
Asia Post is not responsible for the content of external sites.